Literature DB >> 7534998

In vivo treatment with endotoxin induces nitric oxide synthase in rat main pulmonary artery.

M J Griffiths1, S Liu, N P Curzen, M Messent, T W Evans.   

Abstract

Our aim was to demonstrate increased NO activity from inducible NO synthase (iNOS) in pulmonary arteries (PA) from rats treated with endotoxin [lipopolysaccharide (LPS), 20 mg/kg ip]. LPS treatment diminished the contractile response of PA to potassium chloride (KCl) and phenylephrine (PE) and increased levels of guanosine 3',5'-cyclic monophosphate (cGMP) in endothelium-denuded vessels. Both the NO synthase (NOS) antagonists NG-monomethyl-L-arginine (L-NMMA; nonselective) and aminoguanidine (selective for iNOS) enhanced PE-induced contraction in endothelium-denuded vessels from LPS-treated rats. Furthermore, L-NMMA-induced contraction of endothelium-denuded vessels from LPS-treated rats was stereospecifically antagonized by L-arginine and associated with decreased cGMP levels. These data suggest that NO is produced in increased amounts from PA smooth muscle after LPS treatment. LPS treatment caused increased expression of mRNA for iNOS in PA. This effect of LPS was attenuated by pretreatment with dexamethasone, suggesting that induction of NOS in PA smooth muscle underlies the increased NO activity associated with LPS administration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7534998     DOI: 10.1152/ajplung.1995.268.3.L509

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.

Authors:  M S H El-Awady; S V Smirnov; M L Watson
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

Review 2.  Endothelial modification of pulmonary vascular tone.

Authors:  N P Curzen; K B Jourdan; J A Mitchell
Journal:  Intensive Care Med       Date:  1996-06       Impact factor: 17.440

3.  Nitric Oxide does not mediate Atrogin-1/MAFbx upregulation by inflammatory mediators.

Authors:  Bingwen Jin; Yi-Ping Li
Journal:  Basic Appl Myol       Date:  2008

4.  Autologous endothelial progenitor cells improve allograft survival in porcine lung transplantation with prolonged ischemia.

Authors:  Yi-Ting Yen; Jun-Neng Roan; Shih-Yuan Fang; Shi-Wei Chang; Yau-Lin Tseng; Chen-Fuh Lam
Journal:  Ann Transl Med       Date:  2016-08

Review 5.  Pathophysiology of pulmonary hypertension in acute lung injury.

Authors:  Laura C Price; Danny F McAuley; Philip S Marino; Simon J Finney; Mark J Griffiths; Stephen John Wort
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-13       Impact factor: 5.464

6.  Role of inflammatory mediators in lipid A analogue (ONO-4007)-induced vascular permeability change in mouse skin.

Authors:  H Ishida; E Fujii; K Irie; T Yoshioka; T Muraki; R Ogawa
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

7.  Plasma levels of nitrites, PGF1alpha, and nitrotyrosine in LPS-treated rats: functional and histochemical implications in aorta.

Authors:  O H Oztürk; A Cetin; S S Ozdem; N Uysal; U A Kayişli; U K Sentürk; A Yeşilkaya
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 4.158

8.  Differential effects of low-dose endotoxin on the cerebral circulation during pregnancy.

Authors:  Marilyn J Cipolla; Emily M Houston; Richard P Kraig; Elizabeth A Bonney
Journal:  Reprod Sci       Date:  2011-06-21       Impact factor: 3.060

9.  Portal hypertension triggers local activation of inducible nitric oxide synthase gene in colonic mucosa.

Authors:  M Ohta; A Kaviani; A S Tarnawski; R Itani; K Sugimachi; I J Sarfeh
Journal:  J Gastrointest Surg       Date:  1997 May-Jun       Impact factor: 3.452

10.  Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat.

Authors:  A Kaviani; M Ohta; R Itani; F Sander; A S Tarnawski; I J Sarfeh
Journal:  J Gastrointest Surg       Date:  1997 Jul-Aug       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.